Cited by 503Probiotics and Fermented FoodsGut microbiota and healthInfant Nutrition and Health

The DOI matches its Crossref record; 133 of the 134 references it cites were found in a registry or an index.

An update on the use and investigation of probiotics in health and disease

Open access

Abstract

Probiotics are derived from traditional fermented foods, from beneficial commensals or from the environment. They act through diverse mechanisms affecting the composition or function of the commensal microbiota and by altering host epithelial and immunological responses. Certain probiotic interventions have shown promise in selected clinical conditions where aberrant microbiota have been reported, such as atopic dermatitis, necrotising enterocolitis, pouchitis and possibly irritable bowel syndrome. However, no studies have been conducted that can causally link clinical improvements to probiotic-induced microbiota changes. Whether a disease-prone microbiota pattern can be remodelled to a more robust, resilient and disease-free state by probiotic administration remains a key unanswered question. Progress in this area will be facilitated by: optimising strain, dose and product formulations, including protective commensal species; matching these formulations with selectively responsive subpopulations; and identifying ways to manipulate diet to modify bacterial profiles and metabolism.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/gutjnl-2012-302504

Cites

133 of 133 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Scope of probiotic products and uses. (A) Probiotics can be found in food, dietary/nutritional supplements, drugs and medical foods. Each product has country-specific legal requirements for allowed claims of efficacy, target populations, safety and risk/benefit assessment. (B) Hypothesised future uses for probiotics in modifying the composition or activities of the microbiota for improved health. (C) A range of health and clinical targets for different probiotics have been studied, encompassing intestinal and extraintestinal sites, and over a range of life stages. The evidence is strongest in the conditions shown in bold. Mechanisms for observed health effects may not be known, but probably include direct or indirect action on the activities and/or populations of gut microbiota and on the intestinal immune system. AAD, antibiotic-associated diarrhoea; CID, common infectious disease; IBS, irritable bowel syndrome; NEC, necrotising enterocolitis; RR, reduced risk; T, treatment; URTI, upper respiratory tract infections.
Figure 1 Scope of probiotic products and uses. (A) Probiotics can be found in food, dietary/nutritional supplements, drugs and medical foods. Each product has country-specific legal requirements for allowed claims of efficacy, target populations, safety and risk/benefit assessment. (B) Hypothesised future uses for probiotics in modifying the composition or activities of the microbiota for improved health. (C) A range of health and clinical targets for different probiotics have been studied, encompassing intestinal and extraintestinal sites, and over a range of life stages. The evidence is strongest in the conditions shown in bold. Mechanisms for observed health effects may not be known, but probably include direct or indirect action on the activities and/or populations of gut microbiota and on the intestinal immune system. AAD, antibiotic-associated diarrhoea; CID, common infectious disease; IBS, irritable bowel syndrome; NEC, necrotising enterocolitis; RR, reduced risk; T, treatment; URTI, upper respiratory tract infections.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 134 references

Cited by

Sorted by citations

Items 201–300 of 503

Metadata

Authors
Sanders, M. E., Guarner, F., Guerrant, R., Holt, P. R., Quigley, E. M., Sartor, R. B., Sherman, P. M., & Mayer, E. A.
Affiliations
  • Dairy & Food Culture Technologies, Centennial, Colorado, USA
  • Vall d'Hebron Hospital Universitari (ES)
  • University of Virginia (US)
  • Rockefeller University (US)
  • Houston Methodist (US)
  • University of North Carolina at Chapel Hill (US)
  • University of Toronto (CA)
  • University of California, Los Angeles (US)
Corresponding author
Mayer, Emeran A
Venue
Gut
Publisher
BMJ
Published
2013-03-08
Volume
62
Issue
5
Pages
787-796
ISSN
  • 0017-5749 (ISSN-L)
  • 1468-3288
OpenAlex
W2148017101
Cited by
503
References
134
Citations by year
2026: 18 · 2025: 23 · 2024: 20 · 2023: 29 · 2022: 29 · 2021: 34 · 2020: 37 · 2019: 29 · 2018: 44 · 2017: 46 · 2016: 52 · 2015: 58 · 2014: 61 · 2013: 22
FWCI
8.55
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • Gut (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion, cc-by-nc)
  • PubMed Central (acceptedVersion, cc-by-nc)
  • Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by-nc)
  • HighWire Press Open Archive (submittedVersion)
  • UNC Libraries
Funders
  • Procter and Gamble
  • Mead Johnson Nutrition
  • Danone
  • Ironwood Pharmaceuticals, Incorporated
  • Alimentary Health
  • Instituto Danone
  • Norgine
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK048351, U01DK082370)
Topics
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Nursing › Nutrition and Dietetics › Infant Nutrition and Health
Keywords
probiotics, gut microbiota, commensal microbiota, atopic dermatitis, necrotizing enterocolitis, pouchitis, irritable bowel syndrome, host immune response, diet and microbiome, microbiota resilience
MeSH terms
Colitis, Ulcerative, Crohn Disease, Cross Infection, Diarrhea, Female, Health Status, Humans, Hypersensitivity, Vaginitis, Colorectal Neoplasms, Meta-Analysis as Topic, Evidence-Based Medicine, Probiotics, Enterocolitis, Necrotizing, Irritable Bowel Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review